Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H20N5O7S.Na |
Molecular Weight | 413.382 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[O-]S(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NNC(=O)[C@@H]3CCCNC3)C1=O
InChI
InChIKey=OWQBTXVLPFNTDR-RIHXGJNQSA-M
InChI=1S/C13H21N5O7S.Na/c19-11(8-2-1-5-14-6-8)15-16-12(20)10-4-3-9-7-17(10)13(21)18(9)25-26(22,23)24;/h8-10,14H,1-7H2,(H,15,19)(H,16,20)(H,22,23,24);/q;+1/p-1/t8-,9-,10+;/m1./s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C13H20N5O7S |
Molecular Weight | 390.392 |
Charge | -1 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02707107
3 g of zidebactam (1 g q8h) and 6 g of cefepime (2 g q8h) or 6
administered as IV infusions every q8h, over a period of 60 minutes.
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:06:52 GMT 2023
by
admin
on
Sat Dec 16 08:06:52 GMT 2023
|
Record UNII |
NHY7N0Y9DG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
91864531
Created by
admin on Sat Dec 16 08:06:52 GMT 2023 , Edited by admin on Sat Dec 16 08:06:52 GMT 2023
|
PRIMARY | |||
|
NHY7N0Y9DG
Created by
admin on Sat Dec 16 08:06:52 GMT 2023 , Edited by admin on Sat Dec 16 08:06:52 GMT 2023
|
PRIMARY | |||
|
1706777-46-9
Created by
admin on Sat Dec 16 08:06:52 GMT 2023 , Edited by admin on Sat Dec 16 08:06:52 GMT 2023
|
PRIMARY |